China’s medical devices industry saw a drop of 16.67% in overall deal activity during November 2022, when compared with the last 12-month average, led by Dunhang Capital, Fengrui Capital, Green River Investment, Junshan Private Equity Fund of Funds and Yuansheng venture capital management’s $13.99m venture financing of Anyipu (Suzhou) Medical Technology, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
A total of 25 deals worth $54.8m were announced in November 2022, compared with the 12-month average of 30 deals.
venture financing was the leading category in the month in terms of volume with 24 deals, which accounted for 96% of all deals.
In second place was M&A with one deal accounting for 4% of overall deal activity in the China’s technology industry during the month.
In terms of value of deals, venture financing was the leading deal category in China’s medical devices industry with total deals worth $54.77m.
China medical devices industry deals in November 2022: Top deals
The top three medical devices industry deals accounted for 76.22% of the overall value during November 2022.
The combined value of the top three medical devices deals stood at $41.77m, against the overall value of $54.8m recorded for the month.
The top three medical devices industry deals of November 2022 tracked by GlobalData were:
1) Dunhang Capital, Fengrui Capital, Green River Investment, Junshan Private Equity Fund of Funds and Yuansheng venture capital management’s $13.99m venture financing deal with Anyipu (Suzhou) Medical Technology
2) The $13.94m venture financing of Henan Sinotech Biotechnology by China SDIC Gaoxin Industrial Investment, Gaochuang Investment Management, Henan Zhongyuan Lianchuang Fund and Zhejiang Puhua Capital
3) MingFeng Capital and Shanghai Shenghe Investment Management’s $13.84m venture financing deal with Jiangsu Chuangying Medical Device